References
Stoughton RB, Cornell RC, Gange RW, et al. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T®) and oral tetracycline 500 mg/day in the treatment of acne vulgaris. Cutis 1980; 26: 424–9
Gratton D, Raymond GP, Guertin-Larochelle S, et al. Topical clindamycin versus systemic tetracycline in the treatment of acne: results of a multiclinic trial. J Am Acad Dermatol 1982; 7: 50–3
Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 1986; 122: 583–4
Product Information. Cleotin T® topical solution. Upjohn, Kalamazoo, MI, 1995
Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257
Milstone EB, McDonalds AJ, Scholhamer CF. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 1981; 117: 154–5
Bourglund E, Hagermark O, Nord CE. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris. Scand J Infect Dis 1984; Suppl.: 76–81
Ball AP, Gray JA, Murdoch JM. Antibacterial drugs today: first of two parts. Drugs 1975; 10: 1–55
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gallerani, M., Ricci, L., Calò, G. et al. Abdominal Pain and Diarrhoea Caused by Topical Clindamycin Phosphate. Clin. Drug Invest. 14, 243–245 (1997). https://doi.org/10.2165/00044011-199714030-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-199714030-00013